21 – 30 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.
(
- Contribution to journal › Article
-
Mark
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
(
- Contribution to journal › Article
-
Mark
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2012
-
Mark
On the immunopathogenesis of systemic lupus erythematosus - Immune complexes, type I interferon system, complement system and platelets
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis?
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article